The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
The 2020 Pediatric Growth Hormone Deficiency Research
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
Research projects that will be considered for Pfizer support will advance the medical knowledge of pediatric growth hormone deficiency.
Projects submitted may include: • Clinical outcomes, quality of life, and patient reported outcomes • Pharmacoeconomics & medication adherence research • Translational or clinical research
Full Proposal Deadline: *July 15, 2020 (Deadline Extended)
Geographic Scope • United States
To be eligible: • The institution and principal investigator (PI) must be based in one of the eligible countries noted above. • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. • Applicant must be affiliated with a host institution • Both early career and experienced investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria
• Individual projects requesting up to $100,000 will be considered. Pfizer anticipates awarding up to 1 grant.